跳至主要内容
临床试验/NCT00363935
NCT00363935撤回4 期

A Randomized, Double-blind, Controlled Study of Dexmedetomidine (Precedex) Infusion for Improving Control of Acute Autonomic Response During Laparoscopic Bariatric Surgery

University of Texas Southwestern Medical Center2 个研究点 分布在 1 个国家开始时间: 2007年1月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
撤回
试验地点
2

研究概览

简要总结

After obtaining informed consent,80 morbidly obese ASA II-III patients undergoing laparoscopic bariatric surgery procedures would be randomly assigned to one of four study groups at UTSWMC at Dallas.Hemodynamic paarameters, recovery times, postoperative pain scores, the need for rescue analgesics and side effects will be recorded.The purpose of this study is to determine the optimal linfusion rate of dexmedetomidine for maintaining cardiovscular stability during general anesthesia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
Double

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects may be included in the study only if they meet all of the following criteria:
  • Age 18 to 70 years
  • Undergo laparoscopic bariatric surgery requiring general anesthesia
  • Be capable of giving informed consent
  • ASA physical status I-III ( Appendix 1)

排除标准

  • Subjects will be excluded from the study for any of the following reasons:
  • With history of hypertension and allergy to dexmedetomidine
  • Patients who have greater than first degree heart block.
  • Performing major intracavitary surgery procedures
  • Patients who are pregnant or breast-feeding
  • History of alcohol or drug abuse

研究者

研究点 (2)

Loading locations...

相似试验

Bariatric Dose-ranging Study With Dexmedetomidine | 临床试验